Full Text (PDF)
Original Article

Uncomplicated Plasmodium Vivax Malaria Treatment in India

Arvind Nath , Arvind Nath

Author Information

Licence:




Journal of Microbiology and Related Research 8(1):p 9-10, January-June 2022. | DOI: http://dx.doi.org/10.21088/jmrr.2395.6623.8122.1

How Cite This Article:

Arvind Nath/Uncomplicated Plasmodium Vivax Malaria Treatment in India/J Microbiol Relat Res. 2022;8(1): 9–10
 


Timeline

Received : N/A         Accepted : N/A          Published : N/A

Abstract

Background: Uncomplicated P. vivax Malaria treatment in India is straightforward because the same regime exists for the North-eastern part of the country and the rest of the country unlike treating uncomplicated P. falciparum Malaria where different regimes exist for these two areas. However, a slightly different approach is needed for the treatment of pregnant patients. oBjectives: To find out what are the antimalarials prescribed in India for treating uncomplicated Vivax Malaria. Methods: By reviewing documents prepared by WHO and NVBDCP. results: It is found that the same regime exists for treating uncomplicated Vivax Malaria whether the patient comes from any part of the country. However, some modifications are made depending on the pregnancy status of the female patient. conclusions: Some more education is required among health care providers on how to treat uncomplicated P. vivax Malaria. This paper addresses this concern.


References

No records found.


About this article


Cite this article

Arvind Nath/Uncomplicated Plasmodium Vivax Malaria Treatment in India/J Microbiol Relat Res. 2022;8(1): 9–10
 


Licence:




Received Accepted Published
N/A N/A N/A

DOI: http://dx.doi.org/10.21088/jmrr.2395.6623.8122.1

Keywords


Article Level Metrics

Last Updated

Monday 22 June 2026, 07:44:30 (IST)


505

Accesses

1
77
00

Citations


NA
NA
NA

Download citation


Article Keywords


Keyword Highlighting

Highlight selected keywords in the article text.


Timeline


Received N/A
Accepted N/A
Published N/A

licence



Access this article



Share